Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations

A Koyyada - Therapies, 2021 - Elsevier
The long-term use of proton pump inhibitors (PPIs) can lead to increased gastric pH,
hypochlorhydria and in some cases to achlorhydria when compared to other acid …

Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice

KY Ho, KA Gwee, YK Cheng, KH Yoon… - Journal of pain …, 2018 - Taylor & Francis
COX2-selective and nonselective (ns) nonsteroidal anti-inflammatory drugs (NSAIDs) are
widely used for chronic pain management. There are marked differences in the risk of …

Physiologic, pathophysiologic, and pharmacologic regulation of gastric acid secretion

ML Schubert - Current opinion in gastroenterology, 2017 - journals.lww.com
Current Opinion in Gastroenterology Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …

[PDF][PDF] Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis

Y Nassar, S Richter - J Bone Metab, 2018 - synapse.koreamed.org
Background: This study's objective was to evaluate the association between protonpump
inhibitor (PPI) use and bone fracture incidence and bone mineral density (BMD) by meta …

A contemporary look at biomechanical models of myocardium

R Avazmohammadi, JS Soares, DS Li… - Annual review of …, 2019 - annualreviews.org
Understanding and predicting the mechanical behavior of myocardium under healthy and
pathophysiological conditions are vital to develo** novel cardiac therapies and promoting …

Adverse events of proton pump inhibitors: potential mechanisms

A Corsonello, F Lattanzio, S Bustacchini… - Current drug …, 2018 - benthamdirect.com
Objective: We aimed at summarizing current evidence about mechanisms for potentially
harmful effects of Proton Pump Inhibitors (PPIs). Methods: A Pubmed search was performed …

National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017

AU Mishuk, L Chen, P Gaillard, S Westrick… - Journal of the American …, 2021 - Elsevier
Abstract Objectives In the United States, proton pump inhibitors (PPIs) are one of the most
commonly prescribed classes of drugs, but contemporary data on national-level utilization …

Current management of gastro-oesophageal reflux disease—treatment costs, safety profile, and effectiveness: a narrative review

T Lata, J Trautman, P Townend… - Gastroenterology …, 2023 - academic.oup.com
Background The purpose of this study was to review the current management of gastro-
oesophageal reflux disease (GORD), including treatment costs, safety profile and …

Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials

M Yang, Q He, F Gao, K Nirantharakumar, T Veenith… - BMC medicine, 2021 - Springer
Background Although randomized controlled trials (RCTs) have suggested a non-significant
increased risk of stroke among proton pump inhibitor (PPI) users, the association has not …

[HTML][HTML] Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction

LC Pinheiro, GH Oliveira-Paula, RL Portella… - Redox biology, 2016 - Elsevier
Proton pump inhibitors (PPIs) are widely used drugs that may increase the cardiovascular
risk by mechanisms not entirely known. While PPIs increase asymmetric dimethylarginine …